vs
科睿唯安(CLVT)与Reddit, Inc.(RDDT)财务数据对比。点击上方公司名可切换其他公司
Reddit, Inc.的季度营收约是科睿唯安的1.2倍($725.6M vs $617.0M)。Reddit, Inc.净利率更高(34.7% vs 0.5%,领先34.2%)。Reddit, Inc.同比增速更快(69.7% vs -6.9%)。Reddit, Inc.自由现金流更多($263.6M vs $89.2M)。过去两年Reddit, Inc.的营收复合增速更高(72.8% vs -0.3%)
科睿唯安是一家英美合资的上市分析服务企业,主要提供订阅制信息服务,覆盖文献计量、科学计量、商业与市场情报领域,同时为医药、生物科技行业提供专利、监管合规相关的竞争分析,也提供商标保护、域名与品牌保护服务,旗下Web of Science产品系列还负责计算学术期刊的影响因子。
Reddit是美国知名的社交新闻聚合与论坛类社交媒体平台,注册用户可发布链接、文字帖、图片、视频等各类内容,其他用户可对内容进行点赞或点踩,内容按主题归类到用户创建的子板块中,获赞更高的内容会排在板块前列,热度足够的内容还将展示在全站首页。
CLVT vs RDDT — 直观对比
营收规模更大
RDDT
是对方的1.2倍
$617.0M
营收增速更快
RDDT
高出76.6%
-6.9%
净利率更高
RDDT
高出34.2%
0.5%
自由现金流更多
RDDT
多$174.4M
$89.2M
两年增速更快
RDDT
近两年复合增速
-0.3%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $617.0M | $725.6M |
| 净利润 | $3.1M | $251.6M |
| 毛利率 | 66.8% | 91.9% |
| 营业利润率 | 6.7% | 31.9% |
| 净利率 | 0.5% | 34.7% |
| 营收同比 | -6.9% | 69.7% |
| 净利润同比 | 101.6% | 254.2% |
| 每股收益(稀释后) | $0.00 | $1.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLVT
RDDT
| Q4 25 | $617.0M | $725.6M | ||
| Q3 25 | $623.1M | $584.9M | ||
| Q2 25 | $621.4M | $499.6M | ||
| Q1 25 | $593.7M | $392.4M | ||
| Q4 24 | $663.0M | $427.7M | ||
| Q3 24 | $622.2M | $348.4M | ||
| Q2 24 | $650.3M | $281.2M | ||
| Q1 24 | $621.2M | $243.0M |
净利润
CLVT
RDDT
| Q4 25 | $3.1M | $251.6M | ||
| Q3 25 | $-28.3M | $162.7M | ||
| Q2 25 | $-72.0M | $89.3M | ||
| Q1 25 | $-103.9M | $26.2M | ||
| Q4 24 | $-191.8M | $71.0M | ||
| Q3 24 | $-65.6M | $29.9M | ||
| Q2 24 | $-304.3M | $-10.1M | ||
| Q1 24 | $-75.0M | $-575.1M |
毛利率
CLVT
RDDT
| Q4 25 | 66.8% | 91.9% | ||
| Q3 25 | 65.0% | 91.0% | ||
| Q2 25 | 67.2% | 90.8% | ||
| Q1 25 | 65.1% | 90.5% | ||
| Q4 24 | 65.7% | 92.6% | ||
| Q3 24 | 66.2% | 90.1% | ||
| Q2 24 | 67.2% | 89.5% | ||
| Q1 24 | 64.9% | 88.6% |
营业利润率
CLVT
RDDT
| Q4 25 | 6.7% | 31.9% | ||
| Q3 25 | 7.1% | 23.7% | ||
| Q2 25 | 1.1% | 13.6% | ||
| Q1 25 | -3.5% | 1.0% | ||
| Q4 24 | -9.4% | 12.4% | ||
| Q3 24 | 3.5% | 2.0% | ||
| Q2 24 | -36.9% | -11.0% | ||
| Q1 24 | 0.8% | -242.5% |
净利率
CLVT
RDDT
| Q4 25 | 0.5% | 34.7% | ||
| Q3 25 | -4.5% | 27.8% | ||
| Q2 25 | -11.6% | 17.9% | ||
| Q1 25 | -17.5% | 6.7% | ||
| Q4 24 | -28.9% | 16.6% | ||
| Q3 24 | -10.5% | 8.6% | ||
| Q2 24 | -46.8% | -3.6% | ||
| Q1 24 | -12.1% | -236.7% |
每股收益(稀释后)
CLVT
RDDT
| Q4 25 | $0.00 | $1.24 | ||
| Q3 25 | $-0.04 | $0.80 | ||
| Q2 25 | $-0.11 | $0.45 | ||
| Q1 25 | $-0.15 | $0.13 | ||
| Q4 24 | $-0.27 | $4.76 | ||
| Q3 24 | $-0.09 | $0.16 | ||
| Q2 24 | $-0.46 | $-0.06 | ||
| Q1 24 | $-0.14 | $-8.19 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | $953.6M |
| 总债务越低越好 | $4.3B | — |
| 股东权益账面价值 | $4.8B | $2.9B |
| 总资产 | $11.1B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.89× | — |
8季度趋势,按日历期对齐
现金及短期投资
CLVT
RDDT
| Q4 25 | $329.2M | $953.6M | ||
| Q3 25 | $318.7M | $911.7M | ||
| Q2 25 | $362.6M | $734.1M | ||
| Q1 25 | $354.0M | $635.7M | ||
| Q4 24 | $295.2M | $562.1M | ||
| Q3 24 | $388.5M | $515.9M | ||
| Q2 24 | $376.4M | $468.0M | ||
| Q1 24 | $361.8M | $968.5M |
总债务
CLVT
RDDT
| Q4 25 | $4.3B | — | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | — | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — | ||
| Q1 24 | $4.6B | — |
股东权益
CLVT
RDDT
| Q4 25 | $4.8B | $2.9B | ||
| Q3 25 | $4.9B | $2.6B | ||
| Q2 25 | $5.0B | $2.4B | ||
| Q1 25 | $5.0B | $2.2B | ||
| Q4 24 | $5.1B | $2.1B | ||
| Q3 24 | $5.5B | $2.0B | ||
| Q2 24 | $5.6B | $1.9B | ||
| Q1 24 | $5.9B | $1.8B |
总资产
CLVT
RDDT
| Q4 25 | $11.1B | $3.2B | ||
| Q3 25 | $11.2B | $2.9B | ||
| Q2 25 | $11.4B | $2.6B | ||
| Q1 25 | $11.5B | $2.4B | ||
| Q4 24 | $11.5B | $2.3B | ||
| Q3 24 | $12.0B | $2.2B | ||
| Q2 24 | $12.1B | $2.1B | ||
| Q1 24 | $12.5B | $2.0B |
负债/权益比
CLVT
RDDT
| Q4 25 | 0.89× | — | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.79× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $159.9M | $266.8M |
| 自由现金流经营现金流 - 资本支出 | $89.2M | $263.6M |
| 自由现金流率自由现金流/营收 | 14.5% | 36.3% |
| 资本支出强度资本支出/营收 | 11.5% | 0.4% |
| 现金转化率经营现金流/净利润 | 51.58× | 1.06× |
| 过去12个月自由现金流最近4个季度 | $365.3M | $684.2M |
8季度趋势,按日历期对齐
经营现金流
CLVT
RDDT
| Q4 25 | $159.9M | $266.8M | ||
| Q3 25 | $181.1M | $185.2M | ||
| Q2 25 | $116.3M | $111.3M | ||
| Q1 25 | $171.2M | $127.6M | ||
| Q4 24 | $141.3M | $90.0M | ||
| Q3 24 | $202.9M | $71.6M | ||
| Q2 24 | $126.2M | $28.4M | ||
| Q1 24 | $176.2M | $32.1M |
自由现金流
CLVT
RDDT
| Q4 25 | $89.2M | $263.6M | ||
| Q3 25 | $115.5M | $183.1M | ||
| Q2 25 | $50.3M | $110.8M | ||
| Q1 25 | $110.3M | $126.6M | ||
| Q4 24 | $59.1M | $89.2M | ||
| Q3 24 | $126.3M | $70.3M | ||
| Q2 24 | $60.3M | $27.2M | ||
| Q1 24 | $111.8M | $29.2M |
自由现金流率
CLVT
RDDT
| Q4 25 | 14.5% | 36.3% | ||
| Q3 25 | 18.5% | 31.3% | ||
| Q2 25 | 8.1% | 22.2% | ||
| Q1 25 | 18.6% | 32.3% | ||
| Q4 24 | 8.9% | 20.8% | ||
| Q3 24 | 20.3% | 20.2% | ||
| Q2 24 | 9.3% | 9.7% | ||
| Q1 24 | 18.0% | 12.0% |
资本支出强度
CLVT
RDDT
| Q4 25 | 11.5% | 0.4% | ||
| Q3 25 | 10.5% | 0.4% | ||
| Q2 25 | 10.6% | 0.1% | ||
| Q1 25 | 10.3% | 0.2% | ||
| Q4 24 | 12.4% | 0.2% | ||
| Q3 24 | 12.3% | 0.4% | ||
| Q2 24 | 10.1% | 0.4% | ||
| Q1 24 | 10.4% | 1.2% |
现金转化率
CLVT
RDDT
| Q4 25 | 51.58× | 1.06× | ||
| Q3 25 | — | 1.14× | ||
| Q2 25 | — | 1.25× | ||
| Q1 25 | — | 4.88× | ||
| Q4 24 | — | 1.27× | ||
| Q3 24 | — | 2.40× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
RDDT
| Advertising | $689.7M | 95% |
| Other Revenue | $35.9M | 5% |